Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Zevra Therapeutics, Inc. (ZVRA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Zevra Therapeutics, Inc. (ZVRA), most recent 12 months reported: revenue $136.07M, net income $58.26M, free cash flow $32.62M. Latest balance sheet on file: liquid cash $221.57M. From SEC filings. Others in Pharmaceutical Preparations: MACROGENICS, INC. · HERON THERAPEUTICS, INC. /DE/ · Karyopharm Therapeutics Inc. · Elite Pharmaceuticals, Inc. · LIFECORE BIOMEDICAL, INC. · Gyre Therapeutics, Inc. · Arcus Biosciences, Inc. · ARS Pharmaceuticals, Inc.

Stock screener

Watchlist